CTP central petroleum limited

1.85%

5.5¢

Future projections, page-3

First 3 Last

colourofmoney

1,368 Posts.

21/03/17

12:37

Post #: 23509038

Originally posted by murrr ↑

Here's another table I shared some 6 months ago - and implications below

This shows share price (with P/E=10) for different NEGI volumes and profit margins

1

2

3

4 NEGI Annual Volume

5 Profit Margin /GJ 0 PJ 5PJ 10PJ 20 PJ 30 PJ 40 PJ

6 $1 0.16 0.23 0.27 0.50 0.73 0.96

7 $2 0.16 0.34 0.50 0.96 1.42 1.89

8 $3 0.16 0.46 0.73 1.42 2.12 2.81

9 $4 0.16 0.57 0.96 1.89 2.81 3.73

10 $5 0.16 0.69 1.19 2.35 3.50 4.66

So I think Cottee has WRONG STRATEGY to maximise shareholder wealth.

Cottee is trying to maximise gas through NEGI, but this requires $40M upfront investment, which he can't find so he is suggesting we sell CTP for 20c per share, to enable someone to benefit from this.

However, if he were to adopt a different strategy ie maximise shareholder wealth rather than maximise gas into NEGI , then we would be better off e.g.
Option 1: only sell 5PJ per year into Negi initially which we may not need much extra money to finance say at most an extra $5-10M, this would mean that by mid 2018 our share price should be around 50c depending on profit margin (possibly more)

Option 2: aim to sell 10PJ per year into NEGI initially which might only require say $10-20M investment (which might be feasible with a CR) then mid 2018 we would have a share price of 70c-$1

In addition we would retain full benefits from the SANTOS JV

Expand

Bingo murr, this is what we have been stating to that rejuvenated central board for some time. As stated in a previous post of mine, there is no need for CR, people are starting to catch on.

CTP Price at posting: 20.0¢ Sentiment: None Disclosure: Held

11 Upvote

0 Great analysis

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.5¢		Change 0.001(1.85%)		Mkt cap ! $40.98M

Open	High	Low	Value	Volume
5.4¢	5.5¢	5.4¢	$91.62K	1.696M

Buyers (Bids)

No.	Vol.	Price($)
1	449381	5.4¢

Sellers (Offers)

Price($)	Vol.	No.
5.8¢	6030	1

View Market Depth

No.	Vol.	Price($)
1	449381	0.054
1	100000	0.053
3	719000	0.052
1	800000	0.051
2	39000	0.050

Price($)	Vol.	No.
0.058	6030	1
0.059	379120	4
0.060	160000	3
0.061	100000	1
0.067	149268	1

Last trade - 15.59pm 27/06/2025 (20 minute delay)

CTP (ASX) Chart

Future projections, page-3

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News


1
2
3
4	NEGI Annual Volume
5	Profit Margin /GJ	0 PJ	5PJ	10PJ	20 PJ	30 PJ	40 PJ
6	$1	0.16	0.23	0.27	0.50	0.73	0.96
7	$2	0.16	0.34	0.50	0.96	1.42	1.89
8	$3	0.16	0.46	0.73	1.42	2.12	2.81
9	$4	0.16	0.57	0.96	1.89	2.81	3.73
10	$5	0.16	0.69	1.19	2.35	3.50	4.66

Future projections, page-3

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News